PL3389679T3 - Sposób liofilizacji próbki mikroflory kałowej - Google Patents
Sposób liofilizacji próbki mikroflory kałowejInfo
- Publication number
- PL3389679T3 PL3389679T3 PL16826115T PL16826115T PL3389679T3 PL 3389679 T3 PL3389679 T3 PL 3389679T3 PL 16826115 T PL16826115 T PL 16826115T PL 16826115 T PL16826115 T PL 16826115T PL 3389679 T3 PL3389679 T3 PL 3389679T3
- Authority
- PL
- Poland
- Prior art keywords
- lyophilisation
- sample
- fecal microbiota
- microbiota
- fecal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1562750A FR3045383B1 (fr) | 2015-12-18 | 2015-12-18 | Procede de lyophilisation d'un echantillon de microbiote fecal |
| PCT/FR2016/053550 WO2017103550A1 (fr) | 2015-12-18 | 2016-12-19 | Procede de lyophilisation d'un echantillon de microbiote fecal |
| EP16826115.4A EP3389679B1 (fr) | 2015-12-18 | 2016-12-19 | Procede de lyophilisation d'un echantillon de microbiote fecal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3389679T3 true PL3389679T3 (pl) | 2020-09-07 |
Family
ID=55300683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16826115T PL3389679T3 (pl) | 2015-12-18 | 2016-12-19 | Sposób liofilizacji próbki mikroflory kałowej |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10736849B2 (pl) |
| EP (1) | EP3389679B1 (pl) |
| JP (1) | JP6948321B2 (pl) |
| KR (1) | KR102341203B1 (pl) |
| CN (1) | CN108430481B (pl) |
| AU (1) | AU2016370600B2 (pl) |
| CA (1) | CA3007289C (pl) |
| DK (1) | DK3389679T3 (pl) |
| ES (1) | ES2777624T3 (pl) |
| FR (1) | FR3045383B1 (pl) |
| HU (1) | HUE048991T2 (pl) |
| IL (1) | IL259888B (pl) |
| PL (1) | PL3389679T3 (pl) |
| PT (1) | PT3389679T (pl) |
| WO (1) | WO2017103550A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3485879A1 (en) | 2017-11-17 | 2019-05-22 | Maat Pharma | Pharmaceutical oral formulation comrpsing bacteria |
| WO2019149266A1 (en) * | 2018-02-02 | 2019-08-08 | The Chinese University Of Hong Kong | Fecal fungome and therapeutic efficacy of fecal microbiota transplantation |
| WO2019165285A1 (en) * | 2018-02-23 | 2019-08-29 | Crestovo Holdings Llc | Microbiome related immunotherapies |
| NL2021365B1 (en) * | 2018-07-20 | 2020-01-29 | Acad Medisch Ct | Fecal matter for prevention or treatment of autoimmune diseases |
| JP7175990B2 (ja) | 2018-03-02 | 2022-11-21 | アカデミッシュ メディッシュ セントラム | 自己免疫疾患の予防または処置のための糞便物質 |
| EP3597202A1 (en) | 2018-07-20 | 2020-01-22 | Maat Pharma | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
| CN110540941A (zh) * | 2019-07-16 | 2019-12-06 | 上海交通大学 | 一种从粪便中提取保存菌液的方法 |
| ES2803099B2 (es) * | 2019-07-22 | 2021-11-08 | Moehs Iberica Sl | Procedimiento de obtención de besilato de remimazolam amorfo |
| FR3103827B1 (fr) * | 2019-12-02 | 2025-04-25 | Genialis | Procede de lyophilisation d’une composition cellulaire cryogenisee et contenant du gaz dissous |
| EP3895716A1 (en) | 2020-04-17 | 2021-10-20 | Maat Pharma | Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients |
| JP2024501818A (ja) | 2020-12-23 | 2024-01-16 | マー ファルマ | 微生物の複合群集を増殖させる方法 |
| EP4086337A1 (en) | 2021-05-06 | 2022-11-09 | Maat Pharma | Method of predicting and then producing a mix of microbiota samples |
| DE102022111013B4 (de) | 2022-05-04 | 2025-04-30 | Labor LS SE & Co. KG | Verfahren zur Extraktion und Konservierung von Mikroorganismen aus einer Stuhlprobe eines Lebewesens |
| EP4369344A1 (en) | 2022-11-08 | 2024-05-15 | Maat Pharma | Determination of microbiota samples to produce a target mix product and prediction of mixes |
| CN116046960A (zh) * | 2022-12-30 | 2023-05-02 | 上海采微生物科技有限公司 | 粪便脂肪酸样品保存液以及粪便脂肪酸样品预处理的方法 |
| EP4606380A1 (en) | 2024-02-22 | 2025-08-27 | Microviable Therapeutics SL | Method for fecal microbiome purification and uses thereof |
| CN120210328B (zh) * | 2025-05-28 | 2025-09-12 | 中国大熊猫保护研究中心 | 一种用于大熊猫粪便dna提取的预处理方法及应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| KR20100088894A (ko) * | 2009-02-02 | 2010-08-11 | 에이엠바이오 (주) | 멤브레인 생물반응기를 이용한 고농도 유산균의 생산방법 및 유산균 동결건조 분말의 제조방법 |
| DK2419114T4 (da) * | 2009-05-01 | 2019-05-27 | Uas Laboratories Llc | Bakteriesammensætninger til profylakse og behandling af degenerative sygdomme |
| EP2552321B1 (en) | 2010-04-02 | 2014-03-12 | Antonius Henricus Petrus Bosch | Auxiliary device for receiving fecal matter |
| CA2807242C (en) | 2010-08-04 | 2017-05-02 | Thomas Julius Borody | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
| WO2014152484A1 (en) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
| BR112013022927A2 (pt) | 2011-03-09 | 2016-12-06 | Univ Minnesota | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição |
| DK2750682T3 (en) | 2011-10-11 | 2016-08-22 | Achim Biotherapeutics Ab | A composition comprising anaerobically cultured human intestinal flora |
| CN104918624A (zh) * | 2012-11-26 | 2015-09-16 | 托马斯·朱利叶斯·波洛迪 | 恢复排泄物微生物群的组合物及其制造和使用方法 |
| MX369877B (es) | 2013-02-04 | 2019-11-25 | Seres Therapeutics Inc | Composiciones y metodos. |
| EP2951283A4 (en) | 2013-02-04 | 2017-01-25 | Seres Therapeutics, Inc. | Compositions and methods |
| EP2991649B1 (en) | 2013-04-30 | 2020-06-03 | Thomas Julius Borody | Compositions for treating obsessive-compulsive disorder |
| US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| KR102099503B1 (ko) | 2013-06-05 | 2020-04-09 | 리바이오틱스, 인코퍼레이티드 | 미생물상 복원 요법(mrt) 조성물 |
| US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US20150037285A1 (en) * | 2013-07-03 | 2015-02-05 | New York University | Methods for efficient transfer of viable and bioactive microbiota |
| CN114159476A (zh) | 2015-05-14 | 2022-03-11 | 克雷斯顿沃控股公司 | 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置 |
| HK1253064A1 (zh) | 2015-06-01 | 2019-06-06 | The University Of Chicago | 通过操纵共生微生物菌群对癌症的治疗 |
| PL3307289T3 (pl) | 2015-06-09 | 2022-01-17 | Rebiotix, Inc. | Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt) |
| US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| HUP1500332A2 (en) | 2015-07-16 | 2017-01-30 | Feher Janos Dr | Compositions for maintaining and restoring microbiota-host symbiosis |
| EP3368050A1 (en) | 2015-10-26 | 2018-09-05 | Crestovo Holdings LLC | Compositions and methods for fecal microbiota-related therapy |
| FR3045384B1 (fr) * | 2015-12-18 | 2020-02-07 | Institut National De La Recherche Agronomique | Composition lyophilisee pour la conservation de microbiote dans son ecosysteme |
| US20180000872A1 (en) | 2016-07-01 | 2018-01-04 | Regents Of The University Of Minnesota | Compositions and methods for c. difficile treatment |
| US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
-
2015
- 2015-12-18 FR FR1562750A patent/FR3045383B1/fr not_active Expired - Fee Related
-
2016
- 2016-12-19 US US16/063,419 patent/US10736849B2/en active Active
- 2016-12-19 EP EP16826115.4A patent/EP3389679B1/fr active Active
- 2016-12-19 CA CA3007289A patent/CA3007289C/fr active Active
- 2016-12-19 AU AU2016370600A patent/AU2016370600B2/en active Active
- 2016-12-19 JP JP2018531198A patent/JP6948321B2/ja active Active
- 2016-12-19 CN CN201680073680.7A patent/CN108430481B/zh active Active
- 2016-12-19 PT PT168261154T patent/PT3389679T/pt unknown
- 2016-12-19 HU HUE16826115A patent/HUE048991T2/hu unknown
- 2016-12-19 DK DK16826115.4T patent/DK3389679T3/da active
- 2016-12-19 ES ES16826115T patent/ES2777624T3/es active Active
- 2016-12-19 PL PL16826115T patent/PL3389679T3/pl unknown
- 2016-12-19 WO PCT/FR2016/053550 patent/WO2017103550A1/fr not_active Ceased
- 2016-12-19 KR KR1020187020068A patent/KR102341203B1/ko active Active
-
2018
- 2018-06-07 IL IL259888A patent/IL259888B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US10736849B2 (en) | 2020-08-11 |
| IL259888B (en) | 2020-08-31 |
| AU2016370600B2 (en) | 2021-07-15 |
| EP3389679B1 (fr) | 2020-02-12 |
| AU2016370600A1 (en) | 2018-06-28 |
| JP6948321B2 (ja) | 2021-10-13 |
| KR20180086506A (ko) | 2018-07-31 |
| ES2777624T3 (es) | 2020-08-05 |
| JP2019501156A (ja) | 2019-01-17 |
| US20180369147A1 (en) | 2018-12-27 |
| CN108430481A (zh) | 2018-08-21 |
| DK3389679T3 (da) | 2020-03-16 |
| CA3007289A1 (fr) | 2017-06-22 |
| CA3007289C (fr) | 2022-05-03 |
| PT3389679T (pt) | 2020-04-21 |
| HUE048991T2 (hu) | 2020-09-28 |
| KR102341203B1 (ko) | 2021-12-20 |
| WO2017103550A1 (fr) | 2017-06-22 |
| IL259888A (en) | 2018-07-31 |
| CN108430481B (zh) | 2021-12-28 |
| FR3045383B1 (fr) | 2019-06-14 |
| EP3389679A1 (fr) | 2018-10-24 |
| FR3045383A1 (fr) | 2017-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE048991T2 (hu) | Fekális mikrobióta-minta liofilizálási eljárása | |
| IL255100A0 (en) | Method of preparing a faecal microbiota sample | |
| GB201403096D0 (en) | Sample preparation method | |
| GB201402318D0 (en) | Method for materials analysis | |
| IL252253A0 (en) | A method for microbiome assessment | |
| ZA201608367B (en) | Method for methylation analysis | |
| EP3232190A4 (en) | Method for evaluating state of member | |
| SG11201703178YA (en) | Method for ketonisation of biological material | |
| PL3119886T3 (pl) | Sposób analizy RNA zachowujący liczbę kopii | |
| SG11201802706YA (en) | Method for extracting substance from feces sample | |
| GB201515693D0 (en) | Method for antigen detection | |
| EP3217173A4 (en) | Method for detecting disease | |
| EP3174377A4 (en) | Inspection method | |
| EP3198064A4 (en) | Methods for sample preparation | |
| EP3170629A4 (en) | Inspection method | |
| GB201414419D0 (en) | Method of testing | |
| PL3265732T3 (pl) | Sposób suszenia budowli | |
| EP3327658A4 (en) | Technical spillover effect analysis method | |
| EP3128328A4 (en) | Method for analyzing lipoproteins | |
| SG11201608834SA (en) | Method for evaluating soi substrate | |
| AU2014902582A0 (en) | Method for tomographic reconstuction of a sample | |
| AU2015902664A0 (en) | Method for tomographic reconstruction of a sample | |
| GB201703903D0 (en) | Method of charaterising a DNA sample | |
| EP3274095A4 (en) | Specimen inspection apparatus | |
| AU2014902155A0 (en) | Method for Methylation Analysis |